What is the current valuation of the South Korea contract research-organization market?

The market valuation was $1686.0 Million in 2024. Read More

What is the projected market size for the South Korea contract research-organization market by 2035?

The projected valuation for 2035 is $3412.6 Million. Read More

What is the expected CAGR for the South Korea contract research-organization market from 2025 to 2035?

The expected CAGR during the forecast period 2025 - 2035 is 6.62%. Read More

Which service type generated the highest revenue in the South Korea contract research-organization market?

Clinical Research Services generated $1010.0 Million in 2024 and is projected to reach $2050.0 Million. Read More

What are the key therapeutic areas driving growth in the South Korea contract research-organization market?

Oncology, Cardiology, and Infectious Diseases are key therapeutic areas, with Oncology valued at $500.0 Million in 2024. Read More

Which end-user segment contributed the most to the South Korea contract research-organization market in 2024?

Pharmaceutical Companies contributed $800.0 Million in 2024, indicating strong demand. Read More

What is the revenue range for preclinical services in the South Korea contract research-organization market?

Preclinical Services ranged from $340.0 Million to $680.0 Million in 2024. Read More

How does the revenue for Phase III development compare to other phases in the South Korea contract research-organization market?

Phase III development generated $500.0 Million in 2024, making it one of the highest revenue phases. Read More

Who are the leading players in the South Korea contract research-organization market?

Key players include IQVIA, Labcorp Drug Development, and Charles River Laboratories. Read More

What is the revenue potential for the neurology therapeutic area in the South Korea contract research-organization market?

Neurology is projected to generate between $250.0 Million and $500.0 Million during the forecast period. Read More

South Korea Contract Research Organization Market

ID: MRFR/HC/42400-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

South Korea Contract Research Organization Market Research Report: Size, Share, Trend Analysis By Types Outlook (Drug Discovery, Clinical Development), By Clinical Trial Outlook (Preclinical Trials, Phase I, Phase II, Phase III, Phase IV, Others) and By End Users Outlook (Academic institutes, Pharmaceutical companies, Medical service companies) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Contract Research Organization Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Service Type (USD Million)
  1. 4.1.1 Clinical Research Services
  2. 4.1.2 Preclinical Services
  3. 4.1.3 Laboratory Services
  4. 4.1.4 Consulting Services
2. 4.2 Food, Beverages & Nutrition, BY Therapeutic Area (USD Million)
  1. 4.2.1 Oncology
  2. 4.2.2 Cardiology
  3. 4.2.3 Neurology
  4. 4.2.4 Infectious Diseases
  5. 4.2.5 Endocrinology
3. 4.3 Food, Beverages & Nutrition, BY End User (USD Million)
  1. 4.3.1 Pharmaceutical Companies
  2. 4.3.2 Biotechnology Companies
  3. 4.3.3 Medical Device Companies
  4. 4.3.4 Academic Institutions
4. 4.4 Food, Beverages & Nutrition, BY Phase of Development (USD Million)
  1. 4.4.1 Preclinical
  2. 4.4.2 Phase I
  3. 4.4.3 Phase II
  4. 4.4.4 Phase III
  5. 4.4.5 Phase IV
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 IQVIA (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Labcorp Drug Development (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 PPD (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Syneos Health (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Charles River Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Medpace (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 PRA Health Sciences (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Wuxi AppTec (CN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Celerion (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC AREA
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY END USER
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY PHASE OF DEVELOPMENT
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY SERVICE TYPE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY THERAPEUTIC AREA, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY PHASE OF DEVELOPMENT, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY PHASE OF DEVELOPMENT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY THERAPEUTIC AREA, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY PHASE OF DEVELOPMENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Service Type (USD Million, 2025-2035)

Clinical Research Services
Preclinical Services
Laboratory Services
Consulting Services

Food, Beverages & Nutrition By Therapeutic Area (USD Million, 2025-2035)

Oncology
Cardiology
Neurology
Infectious Diseases
Endocrinology

Food, Beverages & Nutrition By End User (USD Million, 2025-2035)

Pharmaceutical Companies
Biotechnology Companies
Medical Device Companies
Academic Institutions

Food, Beverages & Nutrition By Phase of Development (USD Million, 2025-2035)

Preclinical
Phase I
Phase II
Phase III
Phase IV

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”